Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
12/24/1991 | US5075108 Acylation of mephalan by an anhydride |
12/24/1991 | US5075105 Composition for treatment of progressive myopia |
12/24/1991 | US5075099 Diagnosis, therapy |
12/24/1991 | CA1293448C Ophthalmic solutions and methods for improving the comfort and safety of contact lenses |
12/24/1991 | CA1293445C Cephalosporin injection |
12/24/1991 | CA1293444C Amino acid chelated compositions for delivery to specific biologicaltissue sites |
12/24/1991 | CA1293443C Controlled release of macromolecular polypetides |
12/23/1991 | CA2044908A1 In vivo targeting with bifuncitonal antibodies |
12/22/1991 | CA2044858A1 Method of treating bladder cancer cells |
12/21/1991 | WO1991019474A1 Transdermal administration of buprenorphine |
12/21/1991 | CA2085126A1 Transdermal administration of buprenorphine |
12/21/1991 | CA2044979A1 Coated veterinary implants |
12/19/1991 | WO1991019736A2 Cancer-associated scm-recognition factor, preparation and method of use |
12/19/1991 | CA2084767A1 Cancer-associated scm-recognition factor, preparation and method of use |
12/18/1991 | EP0462071A1 Pharmaceutical resorption-improved somatostatin compositions, their preparation and use |
12/18/1991 | EP0462067A1 Gemfibrozil formulations |
12/18/1991 | EP0462066A1 Amorphous gemfibrozil |
12/18/1991 | EP0462015A1 Process for coating drugs with pH sensitive polymers |
12/18/1991 | EP0461505A1 Spray containing nitroglycerin |
12/18/1991 | EP0461497A1 Use of selective hydrogenated styrol-butadien-copolymers in cosmetic and pharmaceutical compositions |
12/18/1991 | EP0461427A2 Cyclodextrin complex |
12/18/1991 | EP0461245A1 Radiolabeled proteins for diagnostic or therapeutic use |
12/18/1991 | CN1057072A Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing same |
12/17/1991 | US5073544 Transdermal compositions of 1-oxohydrocarbyl-substituted azacyclohexanes |
12/17/1991 | US5073543 Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
12/17/1991 | US5073539 Transdermal administration of zwitterionic drugs |
12/17/1991 | US5073375 Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof |
12/17/1991 | US5073374 Drug delivery with active material, water soluble excipient an d lubricant |
12/17/1991 | US5073366 Analgesic composition useful in providing a temporary relief from symptoms of arthritis |
12/17/1991 | CA1293252C Compositions comprising 1-substituted azacycloalkenes |
12/17/1991 | CA1293193C Compositions comprising n,n-dialkylalkanamides |
12/17/1991 | CA1293192C Compositions comprising 1-substituted azacycloalkanes |
12/16/1991 | WO1991019502A1 Intercellular adhesion mediators |
12/16/1991 | CA2084888A1 Intercellular adhesion mediators |
12/16/1991 | CA2044511A1 Pharmaceutical resorption-improved somatostatin compositions, their preparation and use |
12/16/1991 | CA2044509A1 Amorphous gemfibrozil |
12/15/1991 | WO1991019735A1 Libraries of modified peptides with protease resistance |
12/15/1991 | WO1991019485A1 Injectable slow-release galenical |
12/15/1991 | CA2085118A1 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such |
12/14/1991 | CA2044184A1 Use of selectively hydrogenated styrene/butadiene copolymers in cosmetic and pharmaceutical compositions |
12/13/1991 | CA2085245A1 Aminosteroids for ophthalmic use |
12/12/1991 | WO1991018981A2 Neurotropic growth factors comprising a homeobox peptide |
12/12/1991 | WO1991018940A1 Branched polyanhydrides |
12/12/1991 | WO1991018911A2 Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof |
12/12/1991 | WO1991018630A1 Polyether-substituted tumor agents |
12/12/1991 | WO1991018621A1 The combination of growth hormone and insulin-like growth factor-i enhances growth |
12/12/1991 | WO1991018590A1 Process for the manufacture of porous cellulose matrices |
12/12/1991 | WO1991018570A1 Therapeutically effective topical application of st1435 |
12/12/1991 | WO1991014456A3 Improved compositions for photodynamic therapy |
12/12/1991 | WO1991012021A3 Therapeutic agents, and intermediates for the synthesis thereof |
12/11/1991 | EP0460720A2 A method of extruding liposomes |
12/11/1991 | EP0460607A2 Novel monoclonal antibody to novel antigen associated with human tumors |
12/11/1991 | EP0460588A1 Manufacture process of fast-desintegrating film-formed administration forms |
12/11/1991 | EP0460232A1 Tumor cell growth inhibitor |
12/11/1991 | EP0460100A1 Liposome gel composition and method |
12/11/1991 | EP0460080A1 Orally administerable calcium supplement for cattle. |
12/11/1991 | EP0460064A1 Therapeutic aerosol formulations |
12/11/1991 | EP0460014A1 Chymopapain fragmentation of monoclonal antibodies |
12/11/1991 | EP0452334A4 Mucoadhesive carrier for delivery of therapeutical agent |
12/11/1991 | CN1056812A Pharmaceutical preparation |
12/10/1991 | US5071975 Esterification of sucrose with fatty acid alkyl esters, alkaline catalyst |
12/10/1991 | US5071964 Having phosphatidylinositol lipid anchor; inhibit adhesion of T-cells to other lymphocytes by binding to them |
12/10/1991 | US5071879 C20-26 aliphatic alcohol |
12/10/1991 | US5071657 Device for transdermal administration of active medicinal agents |
12/10/1991 | US5071651 Rotavirus nucleocapsid protein VP6 as a carrier in vaccine compositions |
12/10/1991 | US5071646 Pharmaceutical ion exchange resin composition |
12/10/1991 | US5071644 Using aqueous gel |
12/10/1991 | US5071643 Solvent system enhancing the solubility of pharmaceuticals for encapsulation |
12/10/1991 | US5071642 Nifedipine, nimodipine, nicardipine, nitrendipine, nisoldipine or felodipine drugs for treatment of circulatory disorders and high blood pressure |
12/10/1991 | US5071640 Cosmetic composition containing a polyoxyethylenated non-ionic surface-active agents with two lipophilic chains |
12/10/1991 | CA1292944C Preparation process for an aqueous pharmaceutical solution of an active principle constituted by an organic acid |
12/10/1991 | CA1292943C Monosaccharide containing wound healing preparation |
12/06/1991 | CA2043951A1 Monoclonal antibody to novel antigen associated with human tumors |
12/05/1991 | DE4017439A1 New PEG ether or ester derivs. of tumour active or diagnostic agents - with longer in vivo lifetime and high levels in tumours, for nuclear medicine, chemotherapy, fluorescent diagnosis of photo-dynamic therapy |
12/04/1991 | EP0459795A1 Oral dosage form of biologically active proteins |
12/04/1991 | EP0459788A2 Modified proteins and methods of producing same |
12/04/1991 | EP0459733A2 Alginate gels |
12/04/1991 | EP0459695A1 Taste masking and sustained release coatings for pharmaceuticals |
12/04/1991 | EP0459632A1 Composition and method for controlling cholesterol |
12/04/1991 | EP0459373A2 Bioadhesive carboxylic polymer composition and method relating thereto |
12/04/1991 | EP0459176A2 Oligophosphates with antiviral activity |
12/04/1991 | EP0459148A2 Dry eye treatment composition |
12/04/1991 | EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs) |
12/04/1991 | CN1056688A Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrine-derivatives |
12/04/1991 | CN1056634A Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
12/03/1991 | US5070081 Agitation in presence of small amount of water |
12/03/1991 | US5070080 Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form |
12/03/1991 | US5069936 Manufacturing protein microspheres |
12/03/1991 | US5069909 Transdermal administration of buprenorphine |
12/03/1991 | US5069908 Transdermal drug delivery, aluminum acetate |
12/03/1991 | US5069904 Alzheimer's disease |
12/03/1991 | US5069896 Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing |
12/03/1991 | CA1292697C Transdermal administration of amines |
12/03/1991 | CA1292693C Pharmaceutical preparation containing omeprazole |
12/03/1991 | CA1292692C Dispersion of water dispersible or alcohol soluble substances in low cloud point lipoidal materials |
12/03/1991 | CA1292686C Pharmaceutical compositions of recombinant interleukin-2 and formulation process |
12/02/1991 | WO1991018613A1 Self-emulsifying glasses |
12/02/1991 | CA2059555A1 Self-emulsifying glasses |
12/01/1991 | CA2043384A1 Bioadhesive carboxylic polymer composition and method relating thereto |
11/28/1991 | WO1991018091A1 Stabilization of biological macromolecular substances and other organic compounds |